Search
Direxion Daily Pharmaceutical & Medical Bull 3X ETF
PILLAdd to Watchlist
15.180USD
+1.450+10.56%
Close 11-06 16:00（ET）
996.00Volume
14.88KTurnover
Today
+10.56%
5 Days
-0.20%
1 Month
+6.23%
6 Months
+12.07%
Year to Date
+23.69%
1 Year
+88.29%
Key Figures
13.860Open
13.730Prev. Close
15.250High
13.860Low
996.00Volume
14.88KTurnover
0.01Volume Ratio
24.14952wk High
8.24152wk Low
48.79KAvg Volume
0.44%Div Yield
0.060Est. Annual Div.
Health CareInvestment Segment
NoInverse ETF
YesLeveraged ETF
3xLeverage Factor
13.889NAV
USDNAV Currency
--P/B
--Price to earnings ratio
Direxion Daily Pharmaceutical & Medical Bull 3X ETF Profile
Ticker SymbolPILL
Asset ClassEquity
Fund ManagerDirexion
DomicileUS
Expense Ratio0.98%
Founded at2017-11-15
Tracking IndexS&P Pharmaceuticals Select Industry
PILL was created on 2017-11-15 by Direxion. The fund's investment portfolio concentrates primarily on health care equity. PILL provides 3x daily exposure to a modified equal-weighted index of pharmaceutical companies in the US.
Top 10 Holdings
No.Name
Price
Change
Chg %
Shares Held
Weight
Market Value
Watchlist
VERADERMICS INC
MANE
138.780
+10.180
+7.92%
2.21K
2.10%
$306.57K
XERIS BIOPHARMA HOLDINGS INC
XERS
15.200
+2.120
+16.21%
28.55K
2.00%
$291.18K
PACIRA BIOSCIENCES INC
PCRX
36.430
+0.010
+0.03%
7.67K
1.92%
$279.34K
4
AMNEAL PHARMACEUTICALS INC
AMRX
20.140
+0.690
+3.55%
12.76K
1.78%
$260.03K
5
ELI LILLY & CO
LLY
1354.000
-10.730
-0.79%
195.00
1.70%
$248.32K
6
MAZE THERAPEUTICS INC
MAZE
34.190
+1.660
+5.10%
7.97K
1.69%
$247.06K
7
PERRIGO CO PLC
PRGO
15.850
+0.140
+0.89%
15.35K
1.68%
$244.95K
8
ZOETIS INC
ZTS
79.400
-2.710
-3.30%
3.00K
1.67%
$243.25K
9
VIATRIS INC
VTRS
19.910
+0.940
+4.96%
13.34K
1.65%
$240.10K
10
PFIZER INC
PFE
29.390
-0.060
-0.20%
7.92K
1.63%
$237.93K
Direxion Daily Pharmaceutical & Medical Bull 3X ETF Technical Analysis
Technical Indicators
Buy
Summary
Buy
Moving Average
Buy
Direxion Daily Pharmaceutical & Medical Bull 3X ETF News
More news coming soon, stay tuned...
Popular Instruments
51290.600
-208.500 (-0.41%)
26964.500
+329.300 (+1.24%)
7380.000
+23.100 (+0.31%)
12797.000
-1.000 (-0.01%)
58142.000
+876.000 (+1.53%)
6140.600
-37.200 (-0.60%)
89.857
-0.176 (-0.20%)
342.370
-1.800 (-0.52%)
186.640
+5.040 (+2.78%)
4065.670
-33.020 (-0.81%)
FAQs
What is the current price of Direxion Daily Pharmaceutical & Medical Bull 3X ETF (PILL)?
The current price of Direxion Daily Pharmaceutical & Medical Bull 3X ETF (PILL) is 15.18. Market data may be delayed; please refer to the timestamp displayed on the page.
What is the 52-week high of Direxion Daily Pharmaceutical & Medical Bull 3X ETF?
The 52-week high of Direxion Daily Pharmaceutical & Medical Bull 3X ETF is 24.15. Please refer to the page timestamp for the latest data.
What is the 52-week low of Direxion Daily Pharmaceutical & Medical Bull 3X ETF?
The 52-week low of Direxion Daily Pharmaceutical & Medical Bull 3X ETF is 8.24. Please refer to the page timestamp for the latest data.
What is the NAV of Direxion Daily Pharmaceutical & Medical Bull 3X ETF?
The NAV of Direxion Daily Pharmaceutical & Medical Bull 3X ETF is 13.89 today. NAV represents the fund’s total assets minus its liabilities and helps indicate its underlying per-share value.
How is Direxion Daily Pharmaceutical & Medical Bull 3X ETF (PILL) performing?
The trading turnover of Direxion Daily Pharmaceutical & Medical Bull 3X ETF (PILL) is 14.88K. Its price changed by 0.66% over the past month, while its one-year return is 76.94%. View the Direxion Daily Pharmaceutical & Medical Bull 3X ETF price chart for more details.
Is Direxion Daily Pharmaceutical & Medical Bull 3X ETF (PILL) a safe investment?
No investment is completely risk-free. The risk level of Direxion Daily Pharmaceutical & Medical Bull 3X ETF (PILL) depends on its underlying assets, strategy, liquidity, fees, and market conditions. Diversification may reduce potential losses but cannot eliminate them, and past performance does not guarantee future results. Before investing, consider whether the fund aligns with your goals and risk tolerance. This is not investment advice.